Blasiak, Agata http://orcid.org/0000-0003-0727-7611
Truong, Anh T. L. http://orcid.org/0000-0003-1551-4437
Remus, Alexandria
Hooi, Lissa
Seah, Shirley Gek Kheng
Wang, Peter http://orcid.org/0000-0002-4925-1738
Chye, De Hoe
Lim, Angeline Pei Chiew
Ng, Kim Tien
Teo, Swee Teng
Tan, Yee-Joo http://orcid.org/0000-0002-2278-4497
Allen, David Michael http://orcid.org/0000-0001-5333-1258
Chai, Louis Yi Ann
Chng, Wee Joo
Lin, Raymond T. P.
Lye, David C. B.
Wong, John Eu-Li
Tan, Gek-Yen Gladys
Chan, Conrad En Zuo
Chow, Edward Kai-Hua
Ho, Dean
Funding for this research was provided by:
Micron Foundation Sun Life Singapore
Future Systems and Technology Directorate Singapore Ministry of Defence
National Research Foundation Singapore and the Singapore Ministry of Education under its Research Centres of Excellence Initiative
Article History
Received: 17 December 2021
Accepted: 1 June 2022
First Online: 30 June 2022
Competing interests
: A.B., E.K-.H.C., and D.H. are co-inventors or previously filed pending patents on artificial intelligence-based therapy development. E.K.-H.C., and D.H. are shareholders of KYAN Therapeutics, which has licensed intellectual property pertaining to AI-based oncology drug development. The findings from this study are being made available for public benefit, and no intellectual property rights arising from the work reported here are being pursued. The remaining authors declare no competing interests.